Intraosseous adenosine for the termination of supraventricular tachycardia in an infant.
In recent years, the intraosseous technique has dramatically improved the speed at which vascular access may be achieved in critically ill children, and adenosine has been shown to rapidly convert supraventricular tachycardia to normal sinus rhythm. Until now, no report has demonstrated that this drug may be effectively given by this route in human beings. This case report describes the successful termination of supraventricular tachycardia in an infant with the intraosseous administration of adenosine.
Friedman
F D
FD
Department of Emergency Medicine, New England Medical Center, Boston, Massachusetts, USA. franklin.friedman@es.nemc.org
D000241:Adenosine / Q000008:administration & dosage* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004630:Emergencies; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D017148:Infusions, Intraosseous; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D000241:Adenosine